Orgenesis Inc. Common Stock
ORGS
ORGS was delisted on the 18th of October, 2024.
26 hedge funds and large institutions have $4.99M invested in Orgenesis Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 11 reducing their positions, and 6 closing their positions.
0% more funds holding
Funds holding: 26 → 26 (0)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
45% less capital invested
Capital invested by funds: $9M → $4.99M (-$4.01M)
82% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 11
96% less call options, than puts
Call options by funds: $4K | Put options by funds: $110K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$129K |
| 2 |
BHB
Bank Hapoalim BM
Tel Aviv,
Israel
|
+$125K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$85.1K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$57.5K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$48.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
E
Ergoteles
New York
|
-$365K |
| 2 |
HF
HRT Financial
New York
|
-$260K |
| 3 |
Squarepoint
New York
|
-$115K |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$66K |
| 5 |
GHA
GW Henssler & Associates
Kennesaw,
Georgia
|
-$54K |
ORGS Hedge Fund Activity: Q4 2021 in Review
26 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Orgenesis Inc. Common Stock (ORGS) for Q4 2021, worth a combined $4.99M — down 45% from $9M a quarter earlier.
Fund positioning in ORGS was balanced in Q4 2021: 6 funds opened new positions, 6 closed out, 2 added to existing stakes and 11 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $129K. The largest seller was Ergoteles, exiting entirely with an estimated $365K sold.
- 26 institutional investors held Orgenesis Inc. Common Stock (ORGS) as of Q4 2021, unchanged from Q3 2021.
- Funds reported $4.99M of Orgenesis Inc. Common Stock stock for Q4 2021, down 45% quarter-over-quarter.
- 6 funds opened new Orgenesis Inc. Common Stock positions in Q4 2021 and 6 closed out, a net change of 0 holders.
- The largest Orgenesis Inc. Common Stock buyer in Q4 2021 was Virtu Financial, an estimated $129K added.
- The largest Orgenesis Inc. Common Stock seller in Q4 2021 was Ergoteles, an estimated $365K sold.
Based on aggregated 13F filings for Q4 2021.